StonvexLoading…
StonvexStonvexStonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Next report date, year-over-year trend, and recent quarter history.
5-factor analysis: Valuation, Growth, Profitability, Momentum, Financial Health.
Factor scoring needs Finnhub-supplied fundamentals — Finnhub returned no fundamental metrics for this ticker. Common for ETFs, foreign filers without US listing depth, recent IPOs, and thinly-traded OTC names.
6-factor scoring with sector-relative rank. Updated daily.
Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-08 | $9.14 | $8.94 | -2.19% | 0.2M |
| 05-11 | $8.84 | $9.03 | +2.15% | 0.4M |
| 05-12 | $8.87 | $9.36 | +5.52% | 0.2M |
| 05-13 | $9.34 | $9.49 | +1.61% | 0.2M |
| 05-14 | $9.49 | $9.49 | +0.00% | 0.3M |
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $75.41M | $270.28M | $194.10M | $122.19M |
Operating Income | $4.30M | $22.95M | $14.58M | $8.94M |
Net Income | $2.58M | $14.93M | $9.29M | $5.78M |
EPS (Diluted) | $0.06 | $0.37 | $0.23 | $0.14 |
Total Assets | $197.36M | $199.15M | $202.36M | $184.60M |
Total Liabilities | $51.56M | $55.63M | $66.86M | $42.98M |
Cash & Equivalents | $9.76M | $13.50M | $11.12M | $20.02M |
Free Cash Flow OCF − CapEx | $1.36M | $11.93M | $2.23M | $-8.50M |
Shares Outstanding | 38.53M | 38.02M | 38.02M | 39.61M |
These are published opinions from external sell-side analysts — not Stonvex recommendations. Ratings may change without notice, may conflict with each other, and may be wrong. Not investment advice.
Consensus aggregated from publicly disclosed sell-side analyst ratings. Stonvex is not a registered investment advisor and does not endorse any of the ratings shown. Past analyst ratings do not predict future price movements.
Viemed Healthcare Inc is a provider of home medical equipment ("HME") and post-acute healthcare services in the United States, with a focus on respiratory, chronic care, and women's health products and services. The Company's primary service offerings focus on effective in-home treatment, with clinical practitioners providing therapy and counseling to patients in their homes using cutting-edge technology. The company generates the majority of its revenue from medical equipment rental, sales, and supply.